after absorption with leucocytes , erythrocytes and serum proteins from normal individuals , the antisera demonstrated significant complement-dependent cytotoxicity against leukaemic cells from patients with acute lymphoblastic leukaemia ( all ) ( 9/11 ) , lsl ( 7/9 ) and chronic lymphocytic leukaemia ( cll ) ( 9/12 ) , with an antibody titre of 1:64 or greater .
C1517806
leukaemic
C0023449
acute lymphoblastic leukaemia